Human Biobanking Applications - Global Trends, Estimates And Forecasts, 2014-2020 - Report Focus
The report “Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:-
Emerging Market Trends
Advancements in the Technological Space
Market Demand Of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Investment Strategies
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
The analysis primarily deals with human biobanking applications market. Further, the subdivided categories include:
1. Stem Cells
2. Blood1 & Blood Products
3. Organs2
4. Advanced Applications
a. Biomarkers
b. Genomics3
c. Drug Discovery
d. Forensics
5. Research
6. Pharmaceuticals
7. Other4
The period considered for the human biobanking applications market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 1250 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 157 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
- I. REPORT FOCUS
- A. INTRODUCTION
- BIOREPOSITORY
- CLASSIFYING BIOBANKS
- STORING SAMPLES IN A BIOBANK
- BIOSPECIMEN SECURITY AND STORAGE
- THE GENERATIONAL EVOLUTION OF BIOBANK
- PUTTING TOGETHER A BIO BANK WITH ITS REQUIREMENTS AND CAPACITIES
- TECHNICAL REQUIREMENTS
- FUNCTIONAL REQUIREMENTS
- BIOREPOSITORY OPERATIONS
- GETTING A BIOREPOSITORY ACCREDITED
- THE ROLE OF SYNTHETIC DATA IN BIOBANK ANALYSIS
- B. BIOBANKING BENEFITS
- CONCLUSION
- C. BIOSPECIMENS (COLLECTION, PROCESSING, STORAGE,
- RETRIEVAL AND DISSEMINATE)
- BIOSPECIMENS IN CANCER RESEARCH
- BIOSPECIMENS - THE LEGACY PLAN
- DECADES OLD SPECIMENS MAY BE TODAY’S RESEARCH TREASURES
- BIOSPECIMEN MANAGEMENT SYSTEM
- THE MODERN APPROACH TO BIOBANKING
- ISOLATING STOMACH-CELL POPULATIONS USING LCM
- RESULTS FROM THE BPV PROGRAM
- EVALUATION OF PRE-ANALYTICAL FACTORS ON IDENTIFICATION
- OF COPY NUMBER VARIATIONS
- THE IMPACT OF EX-VIVO ISCHEMIA TIME ON QUALITY OF RNA
- THE IDEAL PHYSICAL ENVIRONMENT FOR BIOSPECIMENS
- CASE STUDY: ADVANCED IT SYSTEM FOR RESEARCH BIOREPOSITORY
- PHYSICAL PHENOMENON AT LOW TEMPERATURES
- BIOLOGICAL PHENOMENON AT LOW TEMPERATURES
- STORAGE METHODS FOR VARIOUS BIOSPECIMENS
- 1. STORING PROTEINS AND PURIFIED NUCLEIC ACIDS
- 2. STORING CRYO-PRESERVED CELLS
- 3. STORING TISSUES
- CONCLUSION
- 1. COMPILATION OF STUDIES DESCRIBING THE STABILITY OF SPECIFIC BIOMARKERS FOR BIOSPECIMENS
- (BIOFLUIDS, CELLS, TISSUES) AS A FUNCTION OF STORAGE TEMPERATURE/DURATION
- TRANSPORTING BIOSPECIMENS
- EFFECTS OF TRANSPORTATION ON MONONUCLEAR CELLS
- FINDING BIO-SAMPLES
- OUT OF THE COLD-DRY STATE
- BANKING ON SUCCESS FOR PRECISION MEDICINE
- THE CLOSE OF THE ULTIMATE PERIOD IN BIO-BANKING
- COST OF VALUE STUDY: RELATE THE THEORY TO BIOBANKS
- MALFUNCTION COSTS:
- EXTERNAL STOPPAGE COSTS:
- BIOBANK ECONOMIC MODELING TOOL: A COST IMPROVEMENT DEVICE
- FOR CONTINUITY OF BIO-BANKS
- INSTITUTION OF AN ISO15189 ACCREDITED BIO-BANK
- FOR GLOBAL CLINICAL RESEARCH STUDIES
- CRITICAL MOVES TO BUILD BIO-BANKS: STAGE WISE PROCESS
- FOR LOW INCOME NATIONS
- THE INSTITUTION OF A BIO-BANK AND COHORT NETWORK (BCNET)
- FOR LOW AND MIDDLE INCOME COUNTRIES
- BIO-BANKING AND TRANSLATIONAL MEDICINE: THE SCHOLARLY OUTLOOK
- A WORKABLE METHODOLOGY DEVISED BY BIO-BANK GRAZ: A REPRESENTATION
- FOR OTHER UNIVERSITY-BASED INSTITUTIONS
- THE SUSTAINABILITY ISSUE OF A COMMUNITY HOSPITAL-BASED BIO-BANK
- AND CORE MOLECULAR LABORATORY: THE BEAUMONT UNDERSTANDING
- TO MAINTAIN A DISEASE CENTERED BIO-BANKING - AN ACTIVE APPROACH
- D. BIOBANKING PRINCIPLES
- NORMS BASED ON INTERFACE COMPREHENSION
- DATA STANDARDS ARE NOT MAXIMIZED IN RESEARCH BIO-BANKING
- DATA STANDARDS - PROPOSED BY OBBR AND ISBER
- DATA STANDARDS PROGRAM FOR BIO-BANKS
- DESIGN OF A REGISTRY OF STANDARD OPERATING PROTOCOLS
- FOR TISSUE COMPILATION
- E. PATH BREAKING TECHNOLOGIES
- THE BIO-BANK INFORMATION MANAGEMENT SYSTEM LIFE CYCLE ORGANIZATION
- AND THE BIMS CLOUD MANAGEMENT PLATFORM
- AMALGAMATION OF STANDARD PRE-ANALYTICAL CODE WITH
- BIO-BANK ORGANIZATION SOFTWARE FREEZER PRO
- EVALUATION OF COMPUTERIZATION TECHNOLOGIES AND PHYSICAL STORAGE
- AND RECOVERY
- FUTURE OUTLOOK AND CONCERNS IN THE SETUP OF SOFTWARE SOLUTIONS
- IN AN INTERDISCIPLINARY CLINICAL BIOBANK
- A MECHANICAL LABORATORY WORKFLOW FOR STOOL DNA REMOVAL
- CONSISTENT WORKFLOW FOR BIO-MATERIAL APPEALS
- PARTIALLY COMPUTERIZED BIO-BANK SAMPLE PROCESSING WITH A 384 HIGH DENSITY
- SAMPLE TUBE ROBOT DEPLOYED IN CANCER AND CARDIOVASCULAR RESEARCH
- AN AUTONOMOUS APPRAISAL OF THE CRYOXTRACT CXT350 FROZEN BIO-SPECIMEN
- CORING APPLICATION WITH TISSUE AND STOOL FECAL SAMPLES
- HEAT STANDARDIZATION OF TISSUE SAMPLES SUPPORTS MEASUREMENT WITHOUT
- INTRUSION FROM POST-MORTEM OCCURRENCES AND PERMITS FOR REFINEMENT
- BECAUSE OF MINIMIZED INTRA GROUP VARIABILITY
- BIOT CRYOCARRIER - STANDARDIZED CRYOGENIC TEMPERATURE HANDLING OF
- BIOSPECIMENS
- PROTECTION BY VAPORIZATION FOR BIO-BANKING
- OPTIMUM SPECIMEN SECURITY WITH COMPLETE AUTOMATION CHARACTERISTICS:
- THE AUTOMATED LN2 VAPOUR PHASE FREEZER
- EXERCISE OF ELECTRONIC P-CHIPS IN A MONO AND DUOTAGGING SYSTEM
- FOR SAMPLE TUBES USED IN BIO-BANKING
- SAMPLE TRAIL AND PREREQUISITE WITH IPLEX® PRO SAMPLE ID
- USAGE OF AN E-CONSENT SYSTEM FOR BIO-BANK PATIENT CONSENT
- – THE THREE WHYS
- CELL LINE VERIFICATION WITH THE USE OF SNP TRACE™ PANEL:
- A HIGH-THROUGHPUT, AFFORDABLE SNPBASED INTERFACE FOR FINGERPRINTING,
- IDENTIFYING INFECTIVITY, AND ESTABLISH ORIGIN OF DERIVATIVE CELL LINES
- NEXT-GENERATION DNA SEQUENCING WITH SUSTAINED
- PRESERVED SERUM SAMPLES
- AN ASSESSMENT OF FROZEN ALIQUOTTING APPLICATION FOR THE STABILIZATION
- OF SMALL MOLECULE AND PEPTIDES IN BIO-ANALYTICAL TECHNOLOGY
- F. BIOBANKING PERFORMANCES
- PERFORMANCES INSIDE THE BIO-BANK
- ETHICAL, LEGAL AND APPROPRIATE STRATEGIES
- SOCIETAL COMMITMENT FOR GROWTH OF CDC POLICY LEADING SUPERVISION
- OF SPECIMENS ATTAINED FROM AMERICAN INDIAN/ALASKA NATIVE PEOPLE
- LEGAL AND REGULATORY HURDLES THAT IMPACT COMPLETION OF
- AN INTER-INSTITUTIONAL BIO-BANK SYSTEM
- IN –DEPTH APPRAISAL ON BIO-BANKING PERFORMANCES
- SPECIMEN RESEARCH
- SAFEGUARD AND CONTROL SAMPLE DATA
- BIO-SAMPLES PRESERVATION AND SAFETY PRECAUTIONS
- MONITOR SAMPLES THROUGH TRANSPORT
- FARM OUT SAMPLES
- CONCLUSION
- G. BIOBANK APPLICATIONS
- STEM CELLS
- FUNDAMENTAL FEATURES IN SETTING UP A STEM CELL-SPECIFIC BANK
- SAFEGUARDS TO FUTURE HEALTH VIA CORD BLOOD AND CORD TISSUE STEM CELLS
- SAFEGUARD ONES HEALTH FOR YEARS TO COME
- BLOOD AND ITS COMPONENTS
- RED BLOOD CORPUSCLES
- PLASMA
- BLOOD PLATELETS
- TYPES OF BIOBANKS
- ORGAN AND TISSUE BIOBANK FOR THERAPY AND TRANSPLANTATION
- GENETIC BIOBANKS
- POPULATION BIOBANK
- SOME COMMON OBJECTIVES OF BIOBANKS:
- THERAPY FOR THE MOST PREVALENT GENETIC DISORDERS
- PHARMACEUTICALS
- CUSTOMIZED DRUGS
- EXPANSION OF NOVEL DRUGS
- RESEARCH
- STEM CELLS
- A BIOBANK’S IMPACT: ACHIEVING TRANSLATION MEDICINE IN CANCER RESEARCH
- EFFECTS OF A BIOBANK ON CLINICAL RESEARCH
- BIOBANK INVESTIGATIONS ADVANTAGES
- H. BIOBANK - ADVANCED APPLICATIONS
- CURRENT ROLE OF BIO-BANKING IN MEDICAL ENVIRONMENT
- A CASE FOR OUTSOURCING
- A BIOMATERIAL STORAGE PROVIDER
- COLD-CHAIN MANAGEMENT, TRACKING AND MONITORING
- BRAIN BANK
- EXTRACTING A BRAIN
- FIXATION ALTERNATIVES FOR RNA PRESERVATION
- COMPARISON OF THE FLUIDIGM SNP TRACE™ PANEL AND DNAQUAL
- THE CONNECTION BETWEEN CARDIAC TRANSPLANTATION AND BIOBANKS
- GENTYPE-TISSUE EXPRESSION
- FACTORS AFFECTING STORAGE OF BIOLOGICAL TISSUES
- 2. STORAGE TIME, NUMBER, TYPE OF SAMPLE AND AVERAGE RIN VALUES
- LONG-TERM STORAGE OF DNA: OLD AND NEW METHODS
- 3. DNA SAMPLES AND THEIR SOURCE
- CONCLUSION
- I. CANCER BIOBANKING
- THE ROLE OF BIOBANKS IN CANCER RESEARCH
- BIOBANKS: THE BENCHMARKS
- 4. A LIST OF POSSIBLE PRE-ANALYTICAL VARIABLES THAT COULD AFFECT SAMPLES IN A CANCER BIOBANK
- CASE STUDY: JANUS SERUM BANK
- INFORMED CONSENT AMONGST DISADVANTAGED COMMUNITIES
- FOR BIOBANK RESEARCH
- ENHANCING COLLECTION METHODS AT THE UCCITB
- THE ROLE OF THE CCGC IN CANCER RESEARCH IN CHINA
- THE PCBN:
- PROSTATE CANCER
- OVERVIEW
- PROSTATE CANCER BIOBANKING: COLLECTION METHODS
- AND EVALUATION TECHNIQUES
- A PROSTATE CANCER BIOREPOSITORY TO SATISFY INTERNATIONAL
- COLLABORATIVE DEMANDS
- PROCURE PROSTATE CANCER BIOBANK
- MIRROR IMAGE METHOD: A NEW TECHNIQUE FOR HISTOLOGICAL
- ASSESSMENT OF TUMOR SAMPLES
- NEW CONSENTING PROGRAMS IN THE WCB
- NEXT-GENERATION CANCER BIOBANKING: SEQUENCING AND
- PERSONALIZED MEDICINE
- WHAT ARE SUSTAINABILITY METRICS IN A CANCER-ORIENTED BIOBANK?
- ESTIMATING BIOBANK INVENTORY REQUIREMENTS
- PLATFORMS TO SCREEN NEW CANCER-INHIBITING DRUGS
- THE DEVELOPMENT OF NEW TECHNIQUES TO PERFORM DOWNSTREAM ANALYSIS
- OF IMMUNO-STAINED FFPE SLIDES
- A BIOBANK’S ECONOMIC DRIVERS
- THE ROLE OF STANDARDIZED PROCEDURES IN BIOBANK MANAGEMENT
- DECREASING RESEARCH COSTS
- ENHANCING PATIENT CARE AT LOWER COSTS
- BIOBANKS AND CANCER EVOLUTION
- BIOBANK TRENDS
- BIOMARKERS
- THE RELATION BETWEEN BIOMARKERS AND BIOBANKS
- MAXIMIZING CHANCES OF BIOMARKER IDENTIFICATION
- THE EFFECT OF PRE-ANALYTICAL VARIABLES ON TISSUES
- EXAMPLES OF BIOMARKER IDENTIFICATION
- IMMUNE CELLS AS BIOMARKERS FOR EXPOSURE TO IONIZING RADIATION:
- FROZEN TISSUE-CORE ANALYSIS
- STORAGE STABILITY OF CYTOKINE DIABETES BIOMARKERS
- FORENSICS
- DRUG BREAKTHROUGHS
- J. HUMAN BIOBANKING APPLICATIONS - GEOGRAPHY MARKET BRIEFING
- NORTH AMERICA
- 5. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR NORTH AMERICA CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 6. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF NORTH AMERICAN MARKET VALUE - (2017-2020)
- EUROPE
- 7. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR EUROPE CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 8. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF EUROPEAN MARKET VALUE - (2017-2020)
- ASIA-PACIFIC
- 9. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR ASIA-PACIFIC CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 10. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF ASIA-PACIFIC MARKET VALUE - (2017-2020)
- REST OF WORLD
- 11. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER FOR REST OF WORLD CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 12. HUMAN BIOBANKING APPLICATION MARKET - STEM CELLS, ADVANCED APPLICATION, BLOOD AND BLOOD PRODUCTS, ORGANS, RESEARCH, PHARMACEUTICALS AND OTHER - % OF REST OF WORLD MARKET VALUE - (2017-2020)
- K. HUMAN BIOBANKING ADVANCED APPLICATIONS - GEOGRAPHY MARKET BRIEFING
- NORTH AMERICA
- 13. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR NORTH AMERICA CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 14. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF NORTH AMERICAN MARKET VALUE - (2017-2020)
- EUROPE
- 15. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR EUROPE CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 16. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF EUROPEAN MARKET VALUE - (2017-2020)
- ASIA-PACIFIC
- 17. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR ASIA-PACIFIC CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 18. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF ASIA-PACIFIC MARKET VALUE - (2017-2020)
- REST OF WORLD
- 19. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS FOR REST OF WORLD CURRENT TRENDS, ESTIMATES & FORECASTS - (2014-2020, IN USD$ MILLION)
- 20. ADVANCED APPLICATION MARKET - BIOMARKERS, DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF REST OF WORLD MARKET VALUE - (2017-2020)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook